S-Equol

Product Name:
(S)-3-(4-hydroxyphenyl)chroman-7-ol

Molecular Formula:

C₁₅H₁₄O₃

Molecular Weight:
242.27

CAS No.:
531-95-3

Purity:
Specification 1: ≥95.0%
Specification 2: ≥99.0%

Other Products

Description

S-Equol is a naturally occurring metabolite of soy isoflavones and is currently recognized as one of the most effective and safest phytoestrogens.

Specifications

待定

Appearance	White to slight yellow powder
Purity	≥95%
Assay (sodium-free and anhydrous basis)	≥90%
Sodium content	8%~11.5%
Water content	≤8%
pH (100mg/mL water)	9.5-11.5
Triethylamine	≤0.5%
Ethanol	≤1%

Function

Selectively binds to estrogen receptor β (ERβ), providing mild estrogen-like activity.
Helps relieve menopausal symptoms such as hot flashes and night sweats.
Supports bone health by helping maintain bone density.
Supports cardiovascular health by improving vascular function and lipid metabolism.
May improve skin elasticity, hydration, and reduce signs of skin aging.
Supports cognitive health and may help maintain brain function during menopause.
Provides antioxidant and anti-inflammatory effects to protect cells from oxidative stress.

Application Direction

Dietary supplements and functional health foods
Anti-aging cosmetics and skincare products
Men’s health and hair management

Product Advantages

待定

Why Choose Us

Release U Health Product Ltd is located in New York City, with a company investment exceeding tens of millions of US dollars. It boasts facilities spanning tens of thousands of square meters that comply with Good Manufacturing Practice (GMP) standards, supporting large-scale production of biosynthetic fermentation ingredients, medicinal extracts, as well as finished products such as soft candies, liquid bars, and tablets.

Its parent company has received support from major investors including Nestlé of Switzerland and Plug and Play. Through collaborations with various universities, the company has established a research and development platform encompassing cell engineering, pilot-scale testing, 30-ton fermentation, and full purification systems, backed by a robust portfolio of patents and intellectual property rights in publications.